CFDE Data Portal | Search RPS2P28

	Label	Description
	RPS2P28 Gene (Entity type)	ENSG00000179157 - ribosomal protein S2 pseudogene 28
	GSE119369 H10 inhibition 3 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE146982 metformin 7 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE111247 temozolomide LN-308 11 v 9 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE133661 C19orf12 knockdown A-549 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE215461 topotecan 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE236228 penfluridol 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GTEx Thyroid 20-29 vs 30-39 Down Gene Set (Entity type)	A Gene Set from GTEx
	STK32C IDG kinase ARCHS4 coexpression Gene Set (Entity type)	A Gene Set from IDG
	GSE130437 palbociclib 0 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS

RPS2P28

ENSG00000179157 - ribosomal protein S2 pseudogene 28

GSE119369 H10 inhibition 3 v 7 human dn

A Gene Set from LINCS

GSE146982 metformin 7 v 5 human up

A Gene Set from LINCS

GSE111247 temozolomide LN-308 11 v 9 human up

A Gene Set from LINCS

GSE133661 C19orf12 knockdown A-549 0 v 1 human dn

A Gene Set from LINCS

GSE215461 topotecan 0 v 1 human up

A Gene Set from LINCS

GSE236228 penfluridol 0 v 1 human dn

A Gene Set from LINCS

GTEx Thyroid 20-29 vs 30-39 Down

A Gene Set from GTEx

STK32C IDG kinase ARCHS4 coexpression

A Gene Set from IDG

GSE130437 palbociclib 0 v 3 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.